what does vivimed labs do

Vivimed Labs Limited is primarily engaged in the manufacturing of Active Pharmaceuticals Ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulations, with operations based in India.

what products does vivimed labs make

The company manufactures Active Pharmaceutical Ingredients (APIs), active ingredients for home and personal care, hair dyes, finished dosage formulations, specialty chemicals, and retail branded formulations.

what sector is vivimed labs in

Vivimed Labs Limited operates in the pharmaceuticals and specialty chemicals sector, serving both the healthcare and consumer goods industries.

when was vivimed labs founded

Vivimed Labs Limited was established in 1988.

who owns vivimed labs

Vivimed Labs Limited is a publicly listed company incorporated in India, owned by its shareholders, with a registered address in Karnataka.

Vivimed Labs Limited (VIVIMEDLAB) Share Price Today — ₹7.65

Vivimed Labs Limited (VIVIMEDLAB) live stock price is ₹7.65 with a change of -1.29% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Vivimed Labs Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Vivimed Labs Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

VIVIMEDLAB

NSEBSE

Vivimed Labs Limited

Healthcare· Pharmaceuticals & Biotechnology· INE526G01021· Scrip: 532660

EN हिन्दी ગુજરાતી मराठी

₹7.65

▼ 0.10 (-1.29%)

20/4/2026, 10:29:40 pm

NSE

₹7.65

▼ 0.10

-1.29%

BSE

₹7.26

▲ 0.38

+0.00%

85 trading days · 1Y period

TODAY 

Open7.81

High8.10

Low7.37

Prev Close7.75

Volume8.29Cr

Value₹0.0Cr

L: 7.37H: 8.10

52 WEEK

Low₹5.15

High₹29.40

10% of 52W range

Info

Face Value₹2

Listed2005-08-17

ISININE526G01021

SeriesT

BSE Scrip532660

Key Metrics

1D

-1.15%

1W

+0.73%

1M

+16.95%

3M

-11.08%

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales0.39

Mkt Cap₹48 Cr

Growth (QoQ)

Revenue+47.38%

PAT-16.22%

EPS-20.00%

Profitability

EBITDA Margin1.8%

Net Margin-16.4%

TTM EBITDA M.6.3%

TTM Net M.-11.2%

Dividend

Yield5.80%

Latest DPS₹0.4

Payout Ratio—

Growth+0.00%

TTM Revenue

₹125 Cr

TTM EBITDA

₹8 Cr

TTM PAT

₹-14 Cr

TTM EPS

₹-1.65

Rev/Share

₹15.0

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	37 Cr	43 Cr	1 Cr	-6 Cr	-6 Cr	₹-0.72
2024-09-30	25 Cr	30 Cr	-1 Cr	-5 Cr	-5 Cr	₹-0.60
2024-06-30	25 Cr	33 Cr	-4 Cr	-8 Cr	-8 Cr	₹-0.97
2024-03-31	39 Cr	40 Cr	12 Cr	7 Cr	5 Cr	₹0.64
2023-12-31	41 Cr	58 Cr	-12 Cr	-17 Cr	-16 Cr	₹-1.24
2023-09-30	34 Cr	56 Cr	-16 Cr	-20 Cr	-20 Cr	₹-2.45
2023-03-31	37 Cr	306 Cr	-172 Cr	-268 Cr	-266 Cr	₹-32.08
2022-12-31	56 Cr	74 Cr	-14 Cr	-18 Cr	-18 Cr	₹-0.22

Shareholding Pattern

CURRENT — 2026-03-31

Promoter7.6%

FII1.6%

Public92.4%

Govt0.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2024-12-27	Other	Annual General Meeting
2023-11-07	Other	Annual General Meeting
2023-03-21	Other	Annual General Meeting
2023-02-10	Other	Annual General Meeting
2020-12-23	Other	Annual General Meeting
2019-09-23	Other	Annual General Meeting
2018-09-19	Dividend	Annual General Meeting/Dividend Re 0.40 Per Share
2017-09-21	Dividend	Annual General Meeting/Dividend - Re 0.40 Per Share
2016-09-22	Other	Annual General Meeting
2016-04-06	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
2015-09-23	Other	Annual General Meeting
2014-09-24	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2013-09-24	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2012-09-21	Dividend	Annual General Meeting/Dividend Rs 3 Per Share
2011-09-26	Dividend	Annual General Meeting And Dividend - Rs.2 Per Share
2010-09-09	Dividend	Annual General Meeting And Dividend Rs.1.50 Per Share
2009-09-24	Other	Agm/Div-Rs.1.50 Per Share
2008-09-22	Dividend	Agm/Dividend - 10%
2007-12-20	Other	Annual General Meeting
2006-09-21	Other	Agm

Earnings Transcripts

Vivimed Labs Limited has informed the Exchange regarding Investor Presentation

20 Aug 2019NSE29K chars

Read →

Vivimed Labs Limited has informed the Exchange regarding Investor Presentation

7 Mar 2019NSE36K chars

Read →

Vivimed Labs Limited has informed the Exchange regarding Investor Presentation

15 Feb 2018NSE

Read →

Vivimed Labs Limited has informed the Exchange regarding Intimation for conference call with analyst...

14 Feb 2018NSE

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-04-30	6.93	6.93	6.69	6.78	48,876
2026-04-29	6.94	7.14	6.78	6.98	68,313
2026-04-28	7.19	7.19	6.81	6.94	29,248
2026-04-27	6.73	6.90	6.48	6.88	54,620
2026-04-24	6.99	7.00	6.55	6.71	74,797
2026-04-23	6.89	7.13	6.60	6.85	1.63L
2026-04-22	7.18	7.18	6.89	6.91	1.89L
2026-04-21	7.63	7.68	7.25	7.25	1.55L
2026-04-20	7.81	8.10	7.37	7.63	1.42L
2026-04-17	7.75	7.75	7.50	7.75	98,693
2026-04-16	7.63	7.79	7.36	7.39	1.47L
2026-04-15	7.60	7.67	7.35	7.63	1.74L
2026-04-13	7.60	7.72	7.00	7.31	1.84L
2026-04-10	7.36	7.36	7.35	7.36	82,178
2026-04-09	6.99	7.01	6.71	7.01	62,777
2026-04-08	6.68	6.68	6.68	6.68	42,802
2026-04-07	6.10	6.37	6.10	6.37	56,709
2026-04-02	5.35	5.80	5.31	5.79	93,126
2026-04-01	5.15	5.54	5.15	5.53	1.15L
2026-03-27	5.80	5.89	5.55	5.55	1.91L
2026-03-25	5.88	6.04	5.80	5.84	2.19L
2026-03-24	6.00	6.14	5.87	5.90	1.59L
2026-03-20	6.63	6.63	6.20	6.28	1.20L
2026-03-19	6.49	6.60	6.31	6.39	2.35L
2026-03-18	6.55	6.69	6.45	6.52	1.01L
2026-03-17	6.70	6.70	6.36	6.42	4.61L
2026-03-16	6.88	7.05	6.54	6.61	1.52L
2026-03-13	7.19	7.19	6.80	6.88	1.98L
2026-03-12	7.15	7.15	6.92	6.96	1.72L
2026-03-11	6.98	7.17	6.96	7.16	2.58L

Frequently Asked Questions

About

Vivimed Labs Limited, listed on the NSE as VIVIMEDLAB, is an Indian pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations. The company operates in the healthcare sector but has faced challenges, including a negative profit of -24.4 crore and a poor sales growth of -35.7% over the past five years, reflecting its current financial difficulties.